4 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 1 | Terminated 1 |
Follow Nose Neoplasms: new trials by email Literature Review of Nose Neoplasms trials Research Report on Nose Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer Celecoxib, Placebo, Quality-of-Life Assessment - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Terminated | University of Utah | 13 | 2019-11-27 | 2025-02-12 |
| Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) Tabelecleucel, Pembrolizumab - Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms | Phase 1 / Phase 2 | Terminated | Atara Biotherapeutics | 12 | 2019-02-19 | 2024-11-14 |
| Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer Carboplatin, Chemoradiotherapy, Cisplatin - Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma | Phase 2 | Terminated | M.D. Anderson Cancer Center | 31 | 2008-06-16 | 2026-07-17 |
| Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer Antineoplaston therapy (Atengenal + Astugenal) - Head and Neck Cancer | Phase 2 | Terminated | Burzynski Research Institute | 7 | 1996-05-06 | 2017-11-21 |
Paranasal Sinus Neoplasms (3) · Carcinoma (2) · Head and Neck Neoplasms (2) · Hypopharyngeal Neoplasms (2) · Laryngeal Neoplasms (2) · Mouth Neoplasms (2) · Nasopharyngeal Neoplasms (2) · Oropharyngeal Neoplasms (2) · Epstein-Barr Virus Infections (1) · Nasopharyngeal Carcinoma (1) · Nasopharyngeal Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
Nose Diseases (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Neoplasms (3) · Neoplasms by Site (3) · Otorhinolaryngologic Diseases (3) · Otorhinolaryngologic Neoplasms (3) · Paranasal Sinus Diseases (3) · Head and Neck Neoplasms (2) · Laryngeal Diseases (2) · Mouth Diseases (2) · Pharyngeal Diseases (2) · Pharyngeal Neoplasms (2) · Stomatognathic Diseases (2)
1,2-diaminocyclohexaneplatinum II citrate (1) · Carboplatin (1) · Celecoxib (1) · Chemoradiotherapy (1) · Cisplatin (1) · Docetaxel (1) · Fluorouracil (1) · Platinum (1) · Radiation (1) · Radiotherapy (1) · antineoplaston A10 (1) · antineoplaston AS 2-1 (1) · dehydroftorafur (1) · pembrolizumab (1)
Atara Biotherapeutics (1) · Burzynski Research Institute (1) · M.D. Anderson Cancer Center (1) · University of Utah (1)
United States (4)
Aditi Mehta, DO (1) · Ehab Y Hanna (1) · Richard Cannon, MD (1) · Stanislaw R. Burzynski, MD, PhD (1)
P30CA042014 (1)